Using circulating cell-free DNA to monitor personalized cancer therapy.

Using circulating cell-free DNA to monitor personalized cancer therapy.

Item
http://www.wikidata.org/entity/Q40460053
A rare case of cavitary lung cancer complicated with mycotic pneumonia and bullous emphysema: A case report and review of the literature.Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.Magnetic Nanowire Networks for Dual-Isolation and Detection of Tumor-Associated Circulating Biomarkers.The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies.The reality of complexity: concomitant genomic alterations in patients with EGFR mutations.Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients.The future of cancer treatment using precision oncogenomics.Promising clinical application of ctDNA in evaluating immunotherapy efficacy
P2860

Using circulating cell-free DNA to monitor personalized cancer therapy.

Item
http://www.wikidata.org/entity/Q40460053
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Using circulating cell-free DNA to monitor personalized cancer therapy.
@en
type
label
Using circulating cell-free DNA to monitor personalized cancer therapy.
@en
prefLabel
Using circulating cell-free DNA to monitor personalized cancer therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Using circulating cell-free DNA to monitor personalized cancer therapy.
@en
P2093
P2860
P304
P31
P356
10.1080/10408363.2017.1299683
P433
P478
P50
P577
P698